Evidence map›Paper›PMID 31406344›Full record

ReviewNature reviews. Endocrinology2019

Addressing gaps in care of people with conditions affecting sex development and maturation.

Olaf Hiort, Martine Cools, Alexander Springer, Ken McElreavey, Andy Greenfield, Stefan A Wudy, Alexandra Kulle, S Faisal Ahmed, Arianne Dessens, Antonio Balsamo and 6 more

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Differences of sex development.Nature reviews. Disease primers · 2025
    Review
  6. Article
  7. Nursing's Role in Advancing Care for Rare Genetic Diseases.The Nursing clinics of North America · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Contexts of care for people with differences of sex development: Diversity is still missing in the laboratory routine.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2023
    Article
  12. Is sex still binary?Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 8 countries.

Olaf HiortDivision of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, University of Lübeck and University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. olaf.hiort@uksh.de.ORCID http://orcid.org/0000-0001-7490-4983
Martine CoolsDepartment of Paediatric Endocrinology, Ghent University Hospital, Ghent, Belgium.
Alexander SpringerDepartment of Paediatric Surgery, Interdisciplinary Centre for Paediatric Urology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-0300-6021
Ken McElreaveyHuman Developmental Genetics, Department of Developmental and Stem Cell Biology, Institut Pasteur, Paris, France.
Andy GreenfieldMammalian Genetics Unit, MRC Harwell Institute, Oxfordshire, UK.ORCID http://orcid.org/0000-0002-1477-1776
Stefan A WudyCentre for Child and Adolescent Medicine, Justus Liebig University, Giessen, Germany.
Alexandra KulleDivision of Paediatric Endocrinology and Diabetes, Christian-Albrechts-University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
S Faisal AhmedDevelopmental Endocrinology Research Group, School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0003-0689-5549
Arianne DessensDepartment of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Centre - Sophia, Rotterdam, The Netherlands.
Antonio BalsamoPaediatric Endocrinology Unit, External Consultant of the Reference Centre for Rare Endocrine Conditions, S. Orsola-Malpighi University Hospital, Bologna, Italy.
Mohamad MaghnieDepartment of Paediatrics, IRCCS, Istituto Giannina Gaslini, University of Genova, Genova, Italy.
Marco BonomiDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Mehul DattaniMolecular Basis of Rare Disease Section, Genetics and Genomic Medicine Programme, University College London, Great Ormond Street Institute of Child Health, London, UK.ORCID http://orcid.org/0000-0002-0365-5809
Luca PersaniDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.ORCID http://orcid.org/0000-0003-2068-9581
Laura AudiGrowth and Development Research Unit, Vall d'Hebron Research Institute (VHIR), Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain.
COST Actions DSDnet and GnRH Network as well as the European Reference Network for Rare Endocrine Conditions (Endo–ERN)
University of Milan · ITGhent University Hospital · BEInstitut Pasteur · FRJustus-Liebig-Universität Gießen · DEChristian-Albrechts-Universität zu Kiel · DEErasmus MC · NLInstituto de Salud Carlos III · ESIstituto Giannina Gaslini · ITUniversity of Glasgow · GBUniversity of Lübeck · DE

Funding

Medical Research Council MC_U142684167
6 · The paper itself

Abstract

Differences of sex development are conditions with discrepancies between chromosomal, gonadal and phenotypic sex. In congenital hypogonadotropic hypogonadism, a lack of gonadotropin activity results primarily in the absence of pubertal development with prenatal sex development being (almost) unaffected in most patients. To expedite progress in the care of people affected by differences of sex development and congenital hypogonadotropic hypogonadism, the European Union has funded a number of scientific networks. Two Actions of the Cooperation of Science and Technology (COST) programmes - DSDnet (BM1303) and GnRH Network (BM1105) - provided the framework for ground-breaking research and allowed the development of position papers on diagnostic procedures and special laboratory analyses as well as clinical management. Both Actions developed educational programmes to increase expertise and promote interest in this area of science and medicine. In this Perspective article, we discuss the success of the COST Actions DSDnet and GnRH Network and the European Reference Network for Rare Endocrine Conditions (Endo-ERN), and provide recommendations for future research.

Indexed as

Disorders of Sex DevelopmentEuropean UnionFemaleHumansMaleProgram DevelopmentPubertySexual DevelopmentSexual Maturation

Identifiers

PMID31406344
OpenAlexW2967561705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.